ATE144419T1 - Hypertensiver faktor des parathyroids - Google Patents

Hypertensiver faktor des parathyroids

Info

Publication number
ATE144419T1
ATE144419T1 AT90905941T AT90905941T ATE144419T1 AT E144419 T1 ATE144419 T1 AT E144419T1 AT 90905941 T AT90905941 T AT 90905941T AT 90905941 T AT90905941 T AT 90905941T AT E144419 T1 ATE144419 T1 AT E144419T1
Authority
AT
Austria
Prior art keywords
parathyroid
hypertensive factor
hypertensive
predictable
synergistic
Prior art date
Application number
AT90905941T
Other languages
English (en)
Inventor
Peter K T Pang
Richard Z Lewanczuk
Christina G Benishin
Toyoji Kaneko
Original Assignee
Peter K T Pang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter K T Pang filed Critical Peter K T Pang
Application granted granted Critical
Publication of ATE144419T1 publication Critical patent/ATE144419T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90905941T 1989-03-22 1990-03-22 Hypertensiver faktor des parathyroids ATE144419T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32745089A 1989-03-22 1989-03-22
US46048290A 1990-01-03 1990-01-03

Publications (1)

Publication Number Publication Date
ATE144419T1 true ATE144419T1 (de) 1996-11-15

Family

ID=26985877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905941T ATE144419T1 (de) 1989-03-22 1990-03-22 Hypertensiver faktor des parathyroids

Country Status (11)

Country Link
US (1) US5354765A (de)
EP (2) EP0416094B1 (de)
JP (1) JP2919607B2 (de)
KR (1) KR0169115B1 (de)
AT (1) ATE144419T1 (de)
AU (2) AU643685B2 (de)
CA (1) CA2030516C (de)
DE (1) DE69028971T2 (de)
FI (1) FI905731A7 (de)
HU (1) HUT70033A (de)
WO (1) WO1990011074A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990011074A1 (en) * 1989-03-22 1990-10-04 Pang Peter K T Parathyroid hypertensive factor
AU674018B2 (en) * 1992-06-12 1996-12-05 Peter K.T. Pang Active component of parathyroid hypertensive factor
US5698549A (en) * 1994-05-12 1997-12-16 Uva Patent Foundation Method of treating hyperactive voiding with calcium channel blockers
ATE363289T1 (de) * 1995-02-20 2007-06-15 Yukio Kato Heilmittel für arthrosis deformans und entzündliche gelenkerkrankungen
AU3161997A (en) * 1996-06-21 1998-01-14 Francis Gossard A novel hypertension related calcium regulated gene (hcarg)
WO2005011660A1 (en) * 2003-07-29 2005-02-10 Abbott Laboratories Use of vitamin d to down regulate the renin-angiotensin-aldosterone system
CN108420828B (zh) * 2018-03-30 2020-12-29 吉林省富生医疗器械有限公司 一种改善残余肾功能的血液透析浓缩物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975539A (en) * 1935-11-15 1976-08-17 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an N,N-bis-(3-phenoxy-2-hydroxy-propyl)-alkylenediamine and method of use
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE3109629A1 (de) * 1981-03-13 1982-09-23 Behringwerke Ag, 3550 Marburg "neues protein (pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung"
US4443549A (en) * 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
DE3414801A1 (de) * 1984-04-19 1985-10-24 Bayer Ag, 5090 Leverkusen 4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
US4599340A (en) * 1985-05-07 1986-07-08 Miles Laboratories, Inc. Enhanced soft tissue flap survival in reconstructive surgery
ATE84713T1 (de) * 1985-05-13 1993-02-15 Miles Inc Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome.
DE3517820A1 (de) * 1985-05-17 1986-11-20 Röhm Pharma GmbH, 6108 Weiterstadt Pharmazeutische praeparate mit antihypertensiver und kardioprotektiver wirkung
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
DE3604149A1 (de) * 1986-02-10 1987-08-13 Rentschler Arzneimittel Arzneimittelkombination
JPH0798742B2 (ja) * 1986-07-03 1995-10-25 ゼリア新薬工業株式会社 徐放性製剤組成物
JPS6396126A (ja) * 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物
US4837171A (en) * 1987-07-02 1989-06-06 The General Hospital Corporation Anti-epiglycanin monoclonal antibodies
AU2812589A (en) * 1987-10-29 1989-05-23 Board Of Regents Of The University Of Washington, The Factors associated with essential hypertension
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
WO1990011074A1 (en) * 1989-03-22 1990-10-04 Pang Peter K T Parathyroid hypertensive factor

Also Published As

Publication number Publication date
AU7937691A (en) 1991-09-12
WO1990011074A1 (en) 1990-10-04
CA2030516C (en) 2000-10-10
EP0722735A1 (de) 1996-07-24
AU5412190A (en) 1990-10-22
US5354765A (en) 1994-10-11
AU643685B2 (en) 1993-11-25
CA2030516A1 (en) 1990-09-23
DE69028971D1 (de) 1996-11-28
EP0416094A4 (en) 1992-03-25
FI905731A0 (fi) 1990-11-20
AU648802B2 (en) 1994-05-05
KR0169115B1 (ko) 1999-01-15
DE69028971T2 (de) 1997-05-22
JP2919607B2 (ja) 1999-07-12
EP0416094B1 (de) 1996-10-23
FI905731A7 (fi) 1990-11-20
JPH03505333A (ja) 1991-11-21
HU9201180D0 (en) 1992-07-28
HUT70033A (en) 1995-09-28
EP0416094A1 (de) 1991-03-13
KR920700029A (ko) 1992-02-19

Similar Documents

Publication Publication Date Title
DK0751769T3 (da) Medicinsk behandling under anvendelse af skjoldbruskhormoner
ZA856393B (en) Antidiarrheal compositions and use thereof
NO952469D0 (no) Terapautisk kombinasjon som inneholder interferon
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
DE69530316D1 (de) Antithrombose mittel und gegen den von willebrand-faktor gerichtete monoklonale antikörper
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
NO910962L (no) Munnstykke.
DK0876152T3 (da) Hidtil ukendt administrering af thrombopoietin
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
DE69028971D1 (de) Hypertensiver faktor des parathyroids
GR74770B (de)
EA199800160A1 (ru) Фармацевтическая композиция для лечения сердечно-сосудистых заболеваний, содержащая 3-(2,2,2-триметилгидразиний)пропионат и гамма-бутиробетаин
JPS5551020A (en) Remedy for rheumatism
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.
JPS6483020A (en) Medicinal composition for preventing or treating aids
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
KR970704442A (ko) 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
KR880000094A (ko) 위염치료제
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat
GR3008320T3 (de)
IT1240853B (it) Composizione farmaceutica atta alla somministrazione intranasale comprendente calcitonina e una acil-carnitina
KR930019216A (ko) 종양 치료제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties